Skip to content
Infinite Arena Base

{‘She lacks zero expertise’: this US scientific establishment braces for Høeg's appointment at the Food and Drug Administration.

Given that the US undertakes unprecedented revisions to its vaccine guidelines, a particular individual has surfaced somewhat surprisingly: Tracy Beth Høeg, an American of Danish descent physician and public health researcher who first made her name by casting doubt on coronavirus vaccinations in the pandemic and has concentrated on potential fatalities following Covid vaccination in her recent time at the Food and Drug Administration.

Planned Overhauls to Childhood Immunization Schedule

Agency leaders had intended to announce major changes to the childhood vaccine schedule earlier this month, synchronizing the US with Denmark’s national calendar, sources say – a major change that would put the US out of alignment with a large portion of the world with little proof for benefit. This reveal has been pushed back until the new year.

Instead of the top vaccines chief, Høeg is listed to speak at the event. She was recently named temporary leader of the FDA’s CDER, the fifth appointee to lead the division this calendar year.

A Shift at the Agency

The acting appointment might represent a strengthened alliance between the pharmaceutical and biologics divisions as Høeg and Dr. Prasad consolidate power at the regulatory agency – and it signals a increased emphasis upon dismantling previously authorized immunizations at the FDA.

Dr. Høeg has repeatedly called for ending some pediatric immunization guidelines in the US so as to align more similar to Denmark, a nation with comprehensive healthcare and a population about the size of Wisconsin’s.

In her initial public appearances, she has continued to focus on immunizations – usually the responsibility of Dr. Prasad, chief of the FDA’s vaccine center – as opposed to medication approval.

Concerns Over Qualifications

Høeg has no obvious experience in pharmaceutical research, regulation or leadership, which has been customary for previous heads of the biologics center. She has worked at the FDA as a senior adviser to the FDA chief and the vaccine center since earlier this year.

“She appears not to have any of the qualifications” for overseeing the pharmaceutical oversight division, stated Jonathan Howard. “She lacks experience running a scientific study. She has no expertise in running a sizeable institution. She has no expertise in pharmaceutical oversight.”

Past heads of CBER would “be deeply familiar with legal statutes and the underlying principles of medication creation”, said Dr. Janet Woodcock. “Objectively, she lacks the type of experience that former directors who ran CBER have had.”

The drug center has an enormous portfolio at the FDA, Woodcock emphasized.

“The public just focuses on the innovative therapies, but the generic drug division approves thousands of off-brand pharmaceuticals. There is also a biologic copycat branch, OTC medication office and other areas, and every single one must be managed,” she explained. “The thing you overlook, that’s the thing that I always told people is going to bite you.”

Additionally, a significant leadership aspect to the role, which supervises more than 5,000 employees. “It’s a massive leadership role, if you execute it properly,” she added.

Response and Disputed Initiatives

Regarding questions about Dr. Høeg's credentials and whether this selection signifies increased cooperation among FDA leaders on vaccines, a press secretary said that the “inquiries stem from incorrect presumptions”.

“Her experience aligns with the responsibilities of her job,” the representative explained, noting the period Høeg spent advising the agency head on “medication safety and oversight research, including computational safety modeling and immunization monitoring”.

In her interim role, Dr. Høeg assumes responsibility for the agency head's controversial fast-track approval initiative, a disputed rapid drug-approval program that reportedly troubled her former heads. “How are these medications being selected for this fast-track system? Who is making the decisions?” Howard asked. “There’s a lot of secrecy occurring at the FDA right now.”

Broadly speaking, he said, “the Food and Drug Administration seems to be moving towards less stringent regulations of most medications, with the exception of shots.”

Public Past Work on Immunizations

Regarding immunizations, Dr. Høeg has a more established, if concerning, track record, some experts observe. She released a study using unverified public submissions to determine the incidence of myocarditis following COVID-19 vaccination. She counseled the Florida surgeon general Joseph Ladapo, who allegedly have changed statistics to indicate Covid vaccinations are riskier than they are.

Included in her “desired changes” for the current government included altering regulations for new vaccines and ending “unnecessary” vaccines, she stated following the vote on a online show. At the FDA, Dr. Høeg has reportedly proposed barring teenage boys from obtaining Covid vaccinations.

“She’s an complete true believer who begins with her beliefs and tailors the evidence to fit the evidence in a extremely deceptive, fraudulent manner,” Howard argued.

Taking Control and a “Revenge Tour”

Høeg joined other skeptics, {like|

About the author

Ashley Tran

A dedicated gamer and tech journalist with over a decade of experience covering the gaming industry and analyzing game mechanics.

Infinite Arena Base

Type to search articles.